New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dyne Therapeutics, Inc.
DYN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

3B

Biotechnology

Next Earning date - 04 Nov 2024

3B

Biotechnology

Next Earning date - 04 Nov 2024

33.67USD
Shape1.11 ( 3.41%)
favorite-chart

Relative Strenght

95
favorite-chart

Volume Buzz

-48%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

29%

Quote Panel

Shape
Updated October 12, 2024
1W 6.28 % 1M -1.15 % 3M -22.31 % 1Y 312.62 %

Key Metrics

Shape
  • Market Cap

    3.38B


  • Shares Outstanding

    100.40M


  • Share in Float

    75.29M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    33.67


  • Average Volume

    1.27M


  • Beta

    1.054


  • Range

    6.4-47.45


  • Industry

    Biotechnology


  • Website

    https://www.dyne-tx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

863.00x

P/S Ratio

3.89x

P/B Ratio

0.0

Debt/Equity

-6800.4%

Net Margin

$-3.6

EPS

How DYN compares to sector?

P/E Ratio

Relative Strength

Shape

DYN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$544K

ShapeNaN%

2025-Revenue

$3.11

Shape-344%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

initialise

Previous: Not converted

2024-04-30

Now: Overweight

Raymond James

upgrade

Previous: Not converted

2023-02-27

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.80
vs -0.83

Q4.22

arrow
arrow

N/A

-0.74
vs -1.00

Q1.23

arrow
arrow

N/A

-0.78
vs -0.69

Q2.23

arrow
arrow

N/A

-1.08
vs -1.01

Q3.23

arrow
arrow

N/A

-0.99
vs -0.80

Q4.23

arrow
arrow

N/A

-1.09
vs -0.74

Q1.24

arrow
arrow

N/A

-0.81
vs -0.78

Q2.24

arrow
arrow

N/A

-0.70
vs -1.08

Q3.24

arrow
arrow

N/A

-0.70
vs -0.99

Q4.24

arrow
arrow

N/A

-0.74
vs -1.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

3.8M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-16%

-0.16
vs -0.18

Q4.22

arrow
arrow

-15%

-0.15
vs -0.16

Q1.23

arrow
arrow

-18%

-0.18
vs -0.15

Q2.23

arrow
arrow

-31%

-0.31
vs -0.18

Q3.23

arrow
arrow

-40%

-0.40
vs -0.31

Q4.23

arrow
arrow

-73%

-0.73
vs -0.40

Q1.24

arrow
arrow

-14%

-0.14
vs -0.73

Q2.24

arrow
arrow

-8%

-0.08
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

103

103
vs 88

17%

Q4.22

arrow
arrow

115

115
vs 103

12%

Q1.23

arrow
arrow

128

128
vs 115

11%

Q2.23

arrow
arrow

120

120
vs 128

-6%

Q3.23

arrow
arrow

120

120
vs 120

NA

Q4.23

arrow
arrow

136

136
vs 120

13%

Q1.24

arrow
arrow

175

175
vs 136

29%

Q2.24

arrow
arrow

197

197
vs 175

13%

Earnings Growth

Latest News